Your browser is no longer supported. Please, upgrade your browser.
Settings
TECH Bio-Techne Corporation daily Stock Chart
TECH [NASD]
Bio-Techne Corporation
Index- P/E65.69 EPS (ttm)3.10 Insider Own0.38% Shs Outstand38.58M Perf Week-1.95%
Market Cap7.85B Forward P/E38.73 EPS next Y5.25 Insider Trans-24.77% Shs Float37.73M Perf Month2.86%
Income119.80M PEG5.70 EPS next Q1.34 Inst Own95.40% Short Float1.03% Perf Quarter3.83%
Sales702.60M P/S11.17 EPS this Y20.40% Inst Trans0.08% Short Ratio2.55 Perf Half Y47.64%
Book/sh30.35 P/B6.70 EPS next Y14.27% ROA6.80% Target Price210.71 Perf Year26.00%
Cash/sh4.63 P/C43.90 EPS next 5Y11.52% ROE11.00% 52W Range132.75 - 216.47 Perf YTD40.57%
Dividend1.28 P/FCF63.97 EPS past 5Y-4.30% ROI6.10% 52W High-7.57% Beta1.18
Dividend %0.63% Quick Ratio3.40 Sales past 5Y15.70% Gross Margin66.50% 52W Low50.72% ATR5.09
Employees2000 Current Ratio4.30 Sales Q/Q12.70% Oper. Margin20.90% RSI (14)42.96 Volatility2.62% 2.44%
OptionableYes Debt/Eq0.46 EPS Q/Q103.50% Profit Margin17.30% Rel Volume1.08 Prev Close203.44
ShortableYes LT Debt/Eq0.44 EarningsJul 30 BMO Payout39.80% Avg Volume152.16K Price200.08
Recom2.00 SMA20-3.19% SMA50-0.67% SMA2008.85% Volume60,727 Change-1.65%
Jan-14-19Upgrade Stephens Equal-Weight → Overweight
Oct-31-18Downgrade Craig Hallum Buy → Hold
Oct-17-18Initiated Goldman Neutral $190
Jun-15-18Initiated Argus Buy $185
Jul-13-17Initiated Wells Fargo Market Perform
Feb-09-17Initiated Citigroup Buy $115
Jan-18-17Initiated Deutsche Bank Buy $115
Nov-10-16Resumed Leerink Partners Outperform $122
Jan-21-15Reiterated Robert W. Baird Outperform $102 → $104
Sep-20-13Upgrade Robert W. Baird Neutral → Outperform $76 → $90
Jun-08-12Initiated William Blair Mkt Perform
Feb-01-12Downgrade Robert W. Baird Outperform → Neutral $81 → $71
Feb-04-09Upgrade Robert W. Baird Neutral → Outperform $76 → $69
Feb-04-09Reiterated Leerink Swann Outperform $73.50 → $59.50
Oct-13-08Upgrade Leerink Swann Mkt Perform → Outperform
Apr-18-08Downgrade Robert W. Baird Outperform → Neutral $71
Sep-07-07Downgrade Leerink Swann Outperform → Mkt Perform
Jan-31-07Downgrade First Analysis Sec Overweight → Equal-Weight
Jun-25-19 04:05PM  Bio-Techne Appoints Rupert Vessey to Board of Directors PR Newswire
Jun-21-19 09:15AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Jun-18-19 10:19PM  Heres What Hedge Funds Think About Bio-Techne Corporation (TECH) Insider Monkey
04:15PM  Royce Funds Commentary: Lauren Romeo on 4 Quality Cyclicals GuruFocus.com
Jun-17-19 09:15AM  FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx Prostate IntelliScore (EPI) Test PR Newswire
Jun-13-19 04:35PM  Bio-Techne Receives Approval To Offer The ExoDx Prostate Intelliscore (EPI) Test In New York State PR Newswire
Jun-06-19 08:48AM  If You Like EPS Growth Then Check Out Bio-Techne (NASDAQ:TECH) Before It's Too Late Simply Wall St.
Jun-05-19 09:44AM  The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Gilead Sciences, Repligen, Illumina and Bio-Techne Zacks
09:02AM  Myriad Genetics Announces Study Results Of myRisk Cancer Test Zacks
Jun-04-19 05:30PM  Bio-Techne To Acquire B-MoGen Biotechnologies Inc. PR Newswire
02:12PM  5 Biotech Stocks to Buy Right Now Zacks
Jun-03-19 09:08AM  Bio-Techne To Present At The Goldman Sachs 40th Annual Global Healthcare Conference PR Newswire
May-28-19 09:15AM  Bio-Techne's New Exosome-Based Liquid Biopsies Helping To Advance Personalized Care In Lung Cancer Diagnostics PR Newswire
May-21-19 09:30AM  CBM vs. TECH: Which Stock Is the Better Value Option? Zacks
09:08AM  Bio-Techne To Present At The Jefferies 2019 Global Healthcare Conference PR Newswire
May-14-19 02:10PM  Does Bio-Techne Corporation's (NASDAQ:TECH) Past Performance Indicate A Stronger Future? Simply Wall St.
09:08AM  Bio-Techne To Present At The UBS Global Healthcare Conference PR Newswire
May-06-19 07:00AM  Roche expands partnership with Bio-Techne to offer drug discovery researchers new chromogenic detection options for mRNA ISH tissue analysis PR Newswire
May-02-19 11:46AM  Edited Transcript of TECH earnings conference call or presentation 30-Apr-19 1:00pm GMT Thomson Reuters StreetEvents
09:08AM  Bio-Techne To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference PR Newswire
Apr-30-19 02:55PM  Bio-Techne Corp (TECH) Q3 2019 Earnings Call Transcript Motley Fool
06:30AM  Bio-Techne Releases Third Quarter Fiscal 2019 Results PR Newswire
06:30AM  Bio-Techne Declares Dividend PR Newswire
Apr-25-19 07:12AM  14 acquisitions later, Bio-Techne puts the checkbook away as growth unfolds American City Business Journals
Apr-23-19 10:32AM  Earnings Preview: Techne (TECH) Q3 Earnings Expected to Decline Zacks
Apr-22-19 01:07PM  Hedge Funds Dropped The Ball On Bio-Techne Corporation (TECH) Insider Monkey
09:15AM  Elpiscience and Bio-Techne Announce Strategic Collaboration PR Newswire
Apr-09-19 12:51PM  Are Bio-Techne Corporation's (NASDAQ:TECH) Interest Costs Too High? Simply Wall St.
09:07AM  Bio-Techne To Host Conference Call On April 30, 2019 To Announce Third Quarter 2019 Financial Results PR Newswire
Apr-01-19 05:52PM  5 Tips for Making Money in Penny Stocks InvestorPlace
Mar-28-19 09:09AM  Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling PR Newswire
06:00AM  Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling GlobeNewswire
Mar-05-19 09:08AM  Bio-Techne Scores A Trio Of CiteAb 2019 Awards PR Newswire
08:08AM  Bio-Techne To Present At The Barclays Global Healthcare Conference PR Newswire
Mar-04-19 07:15AM  Report: Exploring Fundamental Drivers Behind Stericycle, B&G Foods, QTS Realty Trust, Trimble, Electronics for Imaging, and Bio-Techne New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Feb-26-19 01:18PM  Bio-Techne Signs Strategic Cooperation Agreement with Lisen Imprinting Diagnostics PR Newswire
Feb-20-19 09:15AM  Bio-Techne To Present At The 8th Annual SVB Leerink Global Healthcare Conference PR Newswire
Feb-14-19 08:48AM  Bio-Techne (TECH) Q2 Earnings Beat, Gross Margin Declines Zacks
Feb-07-19 10:54PM  Edited Transcript of TECH earnings conference call or presentation 5-Feb-19 2:00pm GMT Thomson Reuters StreetEvents
Feb-05-19 07:29PM  Bio-Techne Corp (TECH) Q2 2019 Earnings Conference Call Transcript Motley Fool +6.07%
07:45AM  Techne (TECH) Q2 Earnings and Revenues Surpass Estimates Zacks
06:30AM  Bio-Techne Releases Second Quarter Fiscal 2019 Results PR Newswire
06:30AM  Bio-Techne Declares Dividend PR Newswire
Feb-01-19 10:30AM  What Bio-Techne Corporations (NASDAQ:TECH) ROE Can Tell Us Simply Wall St.
Jan-31-19 02:26PM  ExoDx® Prostate(IntelliScore) (EPI) Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection PR Newswire
Jan-29-19 10:31AM  Analysts Estimate Techne (TECH) to Report a Decline in Earnings: What to Look Out for Zacks
10:29AM  Avalon GloboCare Stock Is an Expensive Mystery InvestorPlace
09:00AM  Bio-Techne Introduces 48-Digoxigenin Cartridge for the Ella Platform PR Newswire
Jan-28-19 09:15AM  Bio-Techne Introduces CE-SDS PLUS for Maurice System PR Newswire
Jan-25-19 02:41PM  5 Innovation-Led Stocks For The Health Care Boom Investopedia
Jan-24-19 09:00AM  Bio-Techne Launches Cell and Gene Therapy Portfolio PR Newswire
Jan-18-19 08:00PM  Five Ways to Profit from the Boom in Life Science Barrons.com
Jan-16-19 09:00AM  Bio-Techne To Host Conference Call On February 5, 2019, To Announce Second Quarter 2019 Financial Results PR Newswire
Jan-14-19 09:30AM  ANIK or TECH: Which Is the Better Value Stock Right Now? Zacks
Jan-02-19 08:19AM  Does Bio-Techne Corporation (NASDAQ:TECH) Have A Good P/E Ratio? Simply Wall St.
Dec-20-18 09:15AM  Bio-Techne To Present At The 37th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-18-18 03:04AM  Hedge Funds Are Crazy About Bio-Techne Corporation (TECH) Insider Monkey
Dec-06-18 12:14PM  Should You Think About Buying Bio-Techne Corporation (NASDAQ:TECH) Now? Simply Wall St.
Dec-04-18 09:15AM  Bio-Techne Releases GMP ROCK Inhibitor and CHIR 99021 for Stem Cell Therapy PR Newswire
Nov-20-18 09:15AM  Bio-Techne To Present At The Citi 2018 Global Healthcare Conference PR Newswire
06:31AM  New Strong Sell Stocks for November 20th Zacks
Nov-08-18 05:05PM  The List: Corporate board pay climbing? Not in Minnesota at least not this year American City Business Journals
Nov-03-18 06:16PM  Edited Transcript of TECH earnings conference call or presentation 30-Oct-18 1:00pm GMT Thomson Reuters StreetEvents
Nov-02-18 07:30AM  Report: Exploring Fundamental Drivers Behind Equity Lifestyle Properties, AvalonBay Communities, Kadant, Mastercard, Bio-Techne, and Erie Indemnity New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-31-18 12:42PM  What Did Bio-Techne Corporations (NASDAQ:TECH) CEO Take Home Last Year? Simply Wall St.
Oct-30-18 02:54PM  Bio-Techne Corp (TECH) Q1 2019 Earnings Conference Call Transcript Motley Fool -6.26%
07:00AM  Bio-Techne Releases First Quarter Fiscal 2019 Results PR Newswire
07:00AM  Bio-Techne Declares Dividend PR Newswire
Oct-26-18 09:15AM  Bio-Techne To Present At The 2018 Stephens NY Investment Conference PR Newswire
Oct-18-18 11:01AM  Bio-Techne Partners Micropoint Bioscience, Expands in China Zacks
Oct-12-18 08:30AM  Bio-Techne Signs Strategic Cooperation Agreement with Micropoint Bioscience PR Newswire
Oct-11-18 09:00AM  Bio-Techne To Host Conference Call On October 30, 2018 To Announce First Quarter 2019 Financial Results PR Newswire
Oct-05-18 08:36AM  How Do Analysts See Bio-Techne Corporation (NASDAQ:TECH) Performing In The Next Couple Of Years? Simply Wall St.
Oct-02-18 09:15AM  Bio-Techne Scientist Presented with the CASSS CE Pharm Award PR Newswire
Oct-01-18 03:07PM  Edited Transcript of TECH earnings conference call or presentation 7-Aug-18 1:00pm GMT Thomson Reuters StreetEvents
Sep-27-18 09:15AM  Bio-Techne Announces Cell and Gene Therapy Initiative PR Newswire
Sep-19-18 09:15AM  Bio-Techne Supports International Antibody Validation Meetings PR Newswire
Sep-18-18 12:02PM  Bio-Techne Announces Publication of Data Demonstrating Additional Clinical Validation of its EPI Test in European Urology Journal PR Newswire
Sep-11-18 08:25AM  The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet Benzinga
Sep-06-18 09:15AM  Bio-Techne Fills a Need for Simple Tools to Study Glycobiology PR Newswire
Sep-05-18 10:00AM  Bio-Techne To Present At The Morgan Stanley 16th Annual Global Healthcare Conference PR Newswire
Aug-31-18 10:40AM  Bio-Techne Corporation (NASDAQ:TECH): Set To Experience A Decrease In Earnings? Simply Wall St.
Aug-28-18 10:00AM  Bio-Techne To Present At The Baird 2018 Global Healthcare Conference PR Newswire
Aug-27-18 06:48PM  Bio-Techne Corp (TECH) Files 10-K for the Fiscal Year Ended on June 30, 2018 GuruFocus.com
Aug-08-18 09:00AM  Bio-Techne Introduces GMP Small Molecules for Stem Cell Therapy Development PR Newswire
Aug-07-18 07:00AM  Bio-Techne Releases Fourth Quarter Fiscal 2018 Results PR Newswire +6.69%
07:00AM  Bio-Techne Declares Dividend PR Newswire
07:00AM  Bio-Techne Corporation to Host Earnings Call ACCESSWIRE
Aug-02-18 09:00AM  Bio-Techne Announces 2018 Investor Day And Webcast PR Newswire
Aug-01-18 04:15PM  Bio-Techne Corporation Completed Its Acquisition of Exosome Diagnostics, Inc. PR Newswire
08:30AM  Market Trends Toward New Normal in Horizon Global, Bio-Techne, Adamis Pharmaceuticals, Kadant, Semgroup, and Provident Financial Services Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jul-24-18 08:00AM  Bio-Techne Introduces New Member of the Simple Western Family, with IR/NIR Detection Capabilities PR Newswire
Jul-12-18 09:00AM  Bio-Techne To Host Conference Call On August 7, 2018 To Announce Fourth Quarter 2018 Financial Results PR Newswire
Jul-10-18 08:00AM  Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets PR Newswire
Jun-26-18 10:00AM  Bio-Techne Expands RNAscope® Assay Services Portfolio to Shorten Development Times and Save Costs PR Newswire
Jun-25-18 04:09PM  Bio-Techne To Acquire Exosome Diagnostics, Inc. PR Newswire
Jun-22-18 07:47AM  Is Bio-Techne Corporation (NASDAQ:TECH) A Financially Strong Company? Simply Wall St.
Jun-07-18 08:00AM  Bio-Techne To Acquire Quad Technologies PR Newswire
Jun-04-18 10:00AM  Bio-Techne To Present At The William Blair 38th Annual Growth Stock Conference PR Newswire
May-24-18 10:00AM  Bio-Techne To Present At The Jefferies 2018 Healthcare Conference PR Newswire
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments, and clinical diagnostic controls worldwide. It operates in three segments: Biotechnology, Protein Platforms, and Diagnostics. The Biotechnology segment offers specialized proteins, such as cytokines and growth factors, immunoassays, antibodies, and related reagents to the biotechnology research community; and in situ hybridization, media, and other cell culture products and reagents. It also provides various products, which serves as predictive biomarkers and therapeutic targets for various human diseases and conditions, such as cancer, autoimmunity, diabetes, hypertension, obesity, inflammation, neurological disorders, and kidney failure. The Protein Platforms segment offers Biologics tools for researchers to interrogate protein purity and identify contaminants during the development and production of biologics; Western blot, an assay for protein analysis and identification; SimplePlex platform, an enzyme-linked immunosorbent assay for use in research and clinical diagnostics; and Single Cell Western platform to elucidate the properties of individual cells to understand cell behavior. The Diagnostics segment provides blood chemistry and gas quality controls, hematology instrument controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market. Bio-Techne Corporation has a strategic cooperation agreement with Micropoint Bioscience; and a strategic collaboration agreement with Elpiscience Biopharmaceuticals Co., Ltd. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. It has strategic partnership with NanoString Technologies. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Eansor Norman DavidSVP - Novus BiologicalsJun 12Sale215.003,117670,1550Jun 14 04:13 PM
HIGGINS JOHN LDirectorJun 04Option Exercise63.035,000315,1508,526Jun 06 04:30 PM
HIGGINS JOHN LDirectorJun 04Sale203.675,0001,018,3463,526Jun 06 04:30 PM
Furlow Brenda S.SVP - General CounselMay 24Option Exercise0.005,40007,589May 29 04:29 PM
Furlow Brenda S.SVP - General CounselMay 24Sale200.005,4001,080,0002,189May 29 04:29 PM
Hippel JamesChief Financial OfficerMay 01Option Exercise86.2535,0003,018,75039,382May 02 04:14 PM
Kelderman KimPresident, Diagnostics & GenomMay 01Option Exercise202.131,667336,9511,667May 02 04:18 PM
Hippel JamesChief Financial OfficerMay 01Sale203.0835,0007,107,6814,382May 02 04:14 PM
BAUMGARTNER ROBERT VDirectorAug 24Option Exercise61.465,000307,30012,712Aug 28 05:30 PM
BAUMGARTNER ROBERT VDirectorAug 24Sale188.475,000942,3347,712Aug 28 05:30 PM
HIGGINS JOHN LDirectorAug 23Option Exercise61.0810,000610,80013,012Aug 27 04:12 PM
HIGGINS JOHN LDirectorAug 23Sale187.9210,0001,879,1733,012Aug 27 04:12 PM
Dinarello Charles ADirectorAug 08Option Exercise63.035,000315,15013,212Aug 10 04:18 PM
Dinarello Charles ADirectorAug 08Sale176.945,000884,6758,212Aug 10 04:18 PM
Eansor Norman DavidSVP - Novus BiologicalsAug 07Option Exercise0.001,19903,465Aug 09 06:29 PM
Furlow Brenda S.SVP - General CounselAug 07Option Exercise0.0095902,627Aug 09 06:26 PM
Hippel JamesChief Financial OfficerAug 07Option Exercise0.002,39805,477Aug 09 06:19 PM
Kummeth Charles R.Chief Executive OfficerAug 07Option Exercise0.0013,816090,288Aug 09 07:22 PM